Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1990 | 12-1989 | 12-1988 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 301 | N/A | N/A |
| Receivables | 28,755 | N/A | N/A |
| Inventories | 25,376 | N/A | N/A |
| Other current assets | 3,344 | 0 | 0 |
| TOTAL | $57,776 | $N/A | $N/A |
| Non-Current Assets | |||
| PPE Net | 29,944 | N/A | N/A |
| Other Non-Current Assets | 13,854 | 0 | 0 |
| TOTAL | $43,798 | $N/A | $N/A |
| Total Assets | $101,574 | $N/A | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | 16,836 | N/A | N/A |
| Accounts payable and accrued liabilities | 5,500 | 0 | 0 |
| Accrued Expenses | 11,742 | N/A | N/A |
| TOTAL | $34,078 | $N/A | $N/A |
| Non-Current Liabilities | |||
| Long Term Debt | 17,236 | N/A | N/A |
| TOTAL | $19,098 | $N/A | $N/A |
| Total Liabilities | $53,176 | $N/A | $N/A |
| Shareholders' Equity | |||
| Common Shares | 942 | N/A | N/A |
| Retained earnings | 26,808 | N/A | N/A |
| Other shareholders' equity | 413 | 0 | 0 |
| TOTAL | $48,398 | $N/A | $N/A |
| Total Liabilities And Equity | $101,574 | $0 | $0 |